Health ❯ Diabetes ❯ Type 2 Diabetes

Treatment Options

GLP-1 Receptor Agonists GLP-1 Agonists Clinical Trials GLP-1 Medications Ozempic Oral Medications Orforglipron Semaglutide Mounjaro vs Ozempic Mounjaro GLP-1 Drugs Medications GLP-1 Therapy Medication Elenolic Acid Injectable Medications CagriSema Wegovy Rybelsus Weight Loss Medications Weight Loss Injections Weight Management Injectable vs Oral Medications GLP-1 Therapies Medication Effects Tirzepatide Tirzepatida Novo Nordisk Semaglutide Injection Insulin Glargine Medication Management

Tirzepatide Linked to Lower Death and Heart Events After PCI and TAVR in New Real-World Analyses

The retrospective TriNetX findings spurred calls for randomized trials to test causation in interventional cardiology.

Wegovy Pill Debuts to Strong U.S. Demand as Next‑Gen Obesity Drugs Near Decisions

Lilly Files Orforglipron Obesity Pill With FDA After Trial Shows Weight-Loss Maintenance

Lilly’s Oral GLP-1 Orforglipron Beats Farxiga and Placebo in Two Phase 3 Diabetes Trials